Mangoceuticals (MGRX) Depreciation & Amortization (CF) (2023 - 2025)

Mangoceuticals has disclosed Depreciation & Amortization (CF) across 3 years of filings, most recently posting $256.0 for Q3 2025.

• In Q3 2025, Depreciation & Amortization (CF) fell 92.59% year-over-year to $256.0; the TTM figure through Jun 2026 stood at $256.0 (down 93.93% YoY), while the FY2024 annual figure was $9936.0, down 60.08% from the prior year.
• Depreciation & Amortization (CF) came in at $256.0 for Q3 2025 at Mangoceuticals, up from $252.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $12515.0 in Q3 2023 to a low of $250.0 in Q1 2025.
• Average Depreciation & Amortization (CF) over 3 years is $3687.6, with a median of $1856.5 recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) slumped 72.38% in 2024 and sank 95.98% in 2025.
• Over 3 years, Depreciation & Amortization (CF) stood at $6292.0 in 2023, then tumbled by 95.95% to $255.0 in 2024, then increased by 0.39% to $256.0 in 2025.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $256.0 in Q3 2025, $252.0 in Q2 2025, and $250.0 in Q1 2025.